Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Pablo Alderuccio

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Blood|July 15, 2025
The Treatment of Marginal Zone LymphomaJuan Pablo Alderuccio, Ariela Noy
Haematologica|June 11, 2026
T-cell engagement in practice: bispecifics in large B-cell lymphomaMichele D Stanchina, Juan Pablo Alderuccio
Expert Review of Hematology|April 22, 2023
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphomaJuan Pablo Alderuccio, Izidore S Lossos
Leukemia & Lymphoma|September 29, 2021
NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapyJuan Pablo Alderuccio, Izidore S Lossos
Blood Reviews|April 30, 2022
ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphomaJuan Pablo Alderuccio, Jeff P Sharman
Oncology (Williston Park, N.Y.)|April 18, 2022
Current Treatments in Marginal Zone LymphomaJuan Pablo Alderuccio, Brad S Kahl
Blood|September 13, 2023
How I treat secondary CNS involvement by aggressive lymphomasJuan Pablo Alderuccio, Lakshmi Nayak, Kate Cwynarski
British Journal of Haematology|September 5, 2019
Central nervous system emergencies in haematological malignanciesMacarena I de la Fuente, Juan Pablo Alderuccio, Izidore S Lossos
Nature Reviews. Clinical Oncology|July 17, 2023
Quantitative PET-based biomarkers in lymphoma: getting ready for primetimeJuan Pablo Alderuccio, Russ A Kuker, Fei Yang, et al.
Cancer|August 9, 2020
Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016)Jorge A Florindez, Juan Pablo Alderuccio, Isildinha M Reis, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Blood|July 15, 2025
The Treatment of Marginal Zone LymphomaJuan Pablo Alderuccio, Ariela Noy
Haematologica|June 11, 2026
T-cell engagement in practice: bispecifics in large B-cell lymphomaMichele D Stanchina, Juan Pablo Alderuccio
Expert Review of Hematology|April 22, 2023
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphomaJuan Pablo Alderuccio, Izidore S Lossos
Leukemia & Lymphoma|September 29, 2021
NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapyJuan Pablo Alderuccio, Izidore S Lossos
Blood Reviews|April 30, 2022
ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphomaJuan Pablo Alderuccio, Jeff P Sharman
Oncology (Williston Park, N.Y.)|April 18, 2022
Current Treatments in Marginal Zone LymphomaJuan Pablo Alderuccio, Brad S Kahl
Blood|September 13, 2023
How I treat secondary CNS involvement by aggressive lymphomasJuan Pablo Alderuccio, Lakshmi Nayak, Kate Cwynarski
British Journal of Haematology|September 5, 2019
Central nervous system emergencies in haematological malignanciesMacarena I de la Fuente, Juan Pablo Alderuccio, Izidore S Lossos
Nature Reviews. Clinical Oncology|July 17, 2023
Quantitative PET-based biomarkers in lymphoma: getting ready for primetimeJuan Pablo Alderuccio, Russ A Kuker, Fei Yang, et al.
Cancer|August 9, 2020
Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016)Jorge A Florindez, Juan Pablo Alderuccio, Isildinha M Reis, et al.
Pageof 5